Artificial Pancreas in Young Children
- PMID: 28520531
- PMCID: PMC5915216
- DOI: 10.1089/dia.2017.0126
Artificial Pancreas in Young Children
Conflict of interest statement
Dr. Forlenza is a consultant for Abbott Diabetes Care and conducts research sponsored by Insulet, Tandem, Medtronic, Dexcom, Animas, Bigfoot, and Type Zero. Dr. Ohman-Hanson has nothing to disclose.
Comment on
-
Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes.Diabetes Technol Ther. 2017 May;19(5):293-298. doi: 10.1089/dia.2016.0424. Epub 2017 Apr 20. Diabetes Technol Ther. 2017. PMID: 28426239 Clinical Trial.
References
-
- FDA Approves First Automated Insulin Delivery Device for Type 1 Diabetics: September 28, 2016. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm522974.htm (accessed March23, 2017)
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
